- Home
- EHC vs PCVX Comparison
EHC vs PCVX Comparison
Compare EHC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- PCVX
- Stock Information
- Founded
- EHC 1983
- PCVX 2013
- Country
- EHC United States
- PCVX United States
- Employees
- EHC N/A
- PCVX N/A
- Industry
- EHC Hospital/Nursing Management
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- EHC Health Care
- PCVX Health Care
- Exchange
- EHC Nasdaq
- PCVX Nasdaq
- Market Cap
- EHC 12.3B
- PCVX 4.4B
- IPO Year
- EHC 1986
- PCVX 2020
- Fundamental
- Price
- EHC $118.48
- PCVX $35.76
- Analyst Decision
- EHC Strong Buy
- PCVX Strong Buy
- Analyst Count
- EHC 8
- PCVX 10
- Target Price
- EHC $123.38
- PCVX $136.50
- AVG Volume (30 Days)
- EHC 714.7K
- PCVX 1.5M
- Earning Date
- EHC 08-04-2025
- PCVX 08-05-2025
- Dividend Yield
- EHC 0.58%
- PCVX N/A
- EPS Growth
- EHC 30.58
- PCVX N/A
- EPS
- EHC 4.84
- PCVX N/A
- Revenue
- EHC $5,512,600,000.00
- PCVX N/A
- Revenue This Year
- EHC $10.73
- PCVX N/A
- Revenue Next Year
- EHC $8.61
- PCVX N/A
- P/E Ratio
- EHC $24.17
- PCVX N/A
- Revenue Growth
- EHC 11.21
- PCVX N/A
- 52 Week Low
- EHC $82.74
- PCVX $27.66
- 52 Week High
- EHC $123.13
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- EHC 46.44
- PCVX 57.77
- Support Level
- EHC $116.39
- PCVX $31.79
- Resistance Level
- EHC $120.35
- PCVX $36.89
- Average True Range (ATR)
- EHC 1.93
- PCVX 1.51
- MACD
- EHC -0.50
- PCVX 0.37
- Stochastic Oscillator
- EHC 31.54
- PCVX 77.65
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.